News
Focus of new ASH VTE guidelines: Thrombophilia testing
New guidelines recommend testing for thrombophilia in patients with VTE provoked by a nonsurgical major transient risk factor or associated with...
News
Venetoclax boosts ibrutinib in high-risk CLL
Most patients in a small study reached undetectable measurable disease after taking combo therapy for high-risk CLL.
News
FDA approves epcoritamab for r/r DLBCL
Epcoritamab for adults with relapsed/refractory diffuse large B-cell lymphoma has been approved by the FDA.
News
Limit PSA screening to men with symptoms
This would reduce potential harms from overdiagnosis and overtreatment, the risk for which is high with the on-demand screening that is the...
Conference Coverage
Pop this question to improve medication adherence
Asking patients about their out-of-pocket medication costs can improve adherence and strengthen the patient-clinician relationship.
News
Drug shortages in U.S. at 10-year high
Among the top five drug classes affected by shortages are chemotherapy drugs used in the treatment of cancer, many of which do not have...
Conference Coverage
Breast cancer survivors need a comprehensive care plan, says doctor
Survivor care for cancer patients should address physical and psychological symptoms through an integrated model, expert says.
News
Review supports continued mask-wearing in health care visits
Masks continue to lower the risk of catching the virus during medical visits.
News
Prior authorization has radiation oncologist deferring to business manager
“This is an example of a process that has run so far amok. It’s just a burden across the board.”
Conference Coverage
PARP inhibitors and breast cancer: Questions remain about wider use
Oncologists are still trying to understand the best drug targets and the value of combo treatments.
News
Mailed HPV test kits boost cervical cancer screening
About 23% of eligible women are overdue for cervical cancer screening by at least a year.
Article
Updated: Federal Practitioner Submission Guidelines
Federal Practitioner welcomes submission of manuscripts on subjects pertinent to physicians, clinical pharmacists, physician...
News
Study explains link between fatty liver and CRC liver metastasis
Findings of a new study suggest that CRC patients with nonalcoholic fatty liver disease may respond differently to treatment than those without...
Conference Coverage
Misdiagnosis, mismatch still common in pancreatic cystic neoplasms
A new study suggests that with better diagnosis a significant proportion of patients with pancreatic cystic neoplasms could be spared from surgery...
News
Immunotherapy plus chemo improves quality of life in NSCLC
The delays reported in time to definitive clinically meaningful deterioration “are particularly pertinent, given the anticipated continued...
Conference Coverage
Genomic assay changes minds on HER2+ BC treatment
In a small study, 56% of oncologists revised plans after getting results of HER2DX tests.
News
DLBCL: Major new treatment breakthroughs
After decades of slow progress, new drugs and therapies are paving the way to more effective treatment of DLBCL.
News
Teledermatology follow-up after Mohs surgery gets a thumbs up from patients
“A big takeaway from our study is that streamlining this process is really essential for successful implementation,” Laura Rezac, MD, said.
Conference Coverage
ASCO honors Hagop Kantarjian, MD, for leukemia research
Noted Lebanese-American oncologist who leads the leukemia department at MD Anderson Cancer Center is to receive a top award at ASCO 2023.
News
Mohs surgery workforce continues to increase
“If the attrition rate remains stable, even with changes in board certification and potential payor eligibility restrictions, the number of...
Conference Coverage
Atezolizumab is associated with enhanced response in triple-negative breast cancer
The addition of atezolizumab to chemotherapy yielded higher pCR than chemotherapy alone.
Clinical Topics
Education Center
Featured Multimedia
Digital Edition
Conference Coverage
-
Pop this question to improve medication adherence -
Breast cancer survivors need a comprehensive care plan, says doctor -
PARP inhibitors and breast cancer: Questions remain about wider use -
Misdiagnosis, mismatch still common in pancreatic cystic neoplasms -
Genomic assay changes minds on HER2+ BC treatment -
Teledermatology follow-up after Mohs surgery gets a thumbs up from patients -
ASCO honors Hagop Kantarjian, MD, for leukemia research -
Mohs surgery workforce continues to increase -
-
Metabolic abnormalities boost obesity-related cancer risk
Question 1 of 5
